The Life-Cycle of Pharmaceuticals in the Environment
- ISBN-10
- 190881845X
- ISBN-13
- 9781908818454
- Category
- Medical
- Pages
- 268
- Language
- English
- Published
- 2015-11-13
- Publisher
- Elsevier
- Authors
- B.M. Peake, R. Braund, Alfred Tong
Description
The Life-Cycle of Pharmaceuticals in the Environment identifies pathways of entry of pharmaceuticals into the environment, beginning with the role of global prescribing and disposal practices. The book then discusses typical levels of common pharmaceuticals and how they can be determined in natural waters such as raw and treated sewage, and in potable water. In addition, sections examine methods currently available to degrade pharmaceuticals in natural waters and some of their ecotoxicological impacts, along with future considerations and the growing concept of product stewardship. Encompasses the full lifecycle of common pharmaceuticals, from prescription and dispensing practices to their occurrence in a range of different types of natural waters and their environmental impact Explores the role of the healthcare system and its affect on users Beneficial for environmental engineers involved in the design and operation of appropriate degradation technologies of the pharmaceutical prescription and disposal practices
Get the book
Similar books
-
Designing Sustainable Technologies, Products and Policies: From Science to Innovation
By Enrico Benetto, Kilian Gericke, Mélanie GuitonThis open access book provides insight into the implementation of Life Cycle approaches along the entire business value chain, supporting environmental, social and economic sustainability related to the development of industrial ...
-
Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks
By Klaus KümmererFollowing the success of the first edition, this pioneering study of pharmaceuticals in the environment has been updated and greatly extended.
-
Ecopharmacovigilance: Multidisciplinary Approaches to Environmental Safety of Medicines
By Leobardo Manuel Gómez-OlivánThis book is aimed at students, academics and research workers in the fields of toxicology, ecology, microbiology and chemistry, as well as those in the pharmaceutical industry, health sector professionals, and members of government bodies ...
-
Pharmaceutical Residues in Freshwater: Hazards and Policy Responses
By Organisation for Economic Co-operation and DevelopmentThis report calls for a better understanding of the effects of pharmaceutical residues in the environment, greater international collaboration and accountability distribution, and policy actions to prevent and remedy emerging concerns.
-
Pharmaceuticals in the Environment: Current Knowledge and Need Assessment to Reduce Presence and Impact
By Benoit RoigNakada, N., Tanishima, T., Shinohara, H., Kiri, K. and Takada, H. (2006) Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research 40(17), ...
-
Pharmaceutical Residues in Freshwater: Hazards and Policy Responses
By OECDThis report calls for a better understanding of the effects of pharmaceutical residues in the environment, greater international collaboration and accountability distribution, and policy actions to prevent and remedy emerging concerns.
-
Green and Sustainable Pharmacy
By Klaus Kümmerer, Maximilian HempelThe book "Sustainable Pharmacy" will address all these issues and will be the first one dealing with this important topic.
-
Wood in Our Future: The Role of Life-Cycle Analysis: Proceedings of a Symposium
By National Research Council, Board on AgricultureThe book also focuses on national and international efforts to develop integrated environmental, economic, and energy accounting methologies.
-
Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks
By Klaus KümmererAherne GW, Hardcastle A, Nield AH (1990) Cytotoxic drugs and the aquatic environment. Estimation of bleomycin in ... Science 301:1027 Greiner P, Ronnefahrt I (2002) Management of environmental risks in the life cycle of pharmaceuticals.
-
Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk
By Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Responsible Sharing of Clinical Trial DataThis book will be of interest to stakeholders across the spectrum of research-from funders, to researchers, to journals, to physicians, and ultimately, to patients.